The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Epstein–Barr virus latent genes
Open accessAbstract
Latent Epstein–Barr virus (EBV) infection has a substantial role in causing many human disorders. The persistence of these viral genomes in all malignant cells, yet with the expression of limited latent genes, is consistent with the notion that EBV latent genes are important for malignant cell growth. While the EBV-encoded nuclear antigen-1 (EBNA-1) and latent membrane protein-2A (LMP-2A) are critical, the EBNA-leader proteins, EBNA-2, EBNA-3A, EBNA-3C and LMP-1, are individually essential for in vitro transformation of primary B cells to lymphoblastoid cell lines. EBV-encoded RNAs and EBNA-3Bs are dispensable. In this review, the roles of EBV latent genes are summarized. The latent form of Epstein-Barr virus (EBV) relies on a small arsenal of genes to manipulate host cell genes and promote cancerous growth. Many people unknowingly harbor EBV, which remains latent in immune and epithelial cells after initial infection. The latent virus is harmless if it remains dormant but if it becomes reactivated it can contribute to a variety of different cancers and immune disorders. Myung-Soo Kang at the Sungkyunkwan University School of Medicine in Korea and Elliott Kieff of Harvard Medical School in the USA review current knowledge regarding the specific genes that become active in the latent virus. Their analysis reveals diverse parallel mechanisms by which EBV removes the blocks that inhibit cell division while at the same time thwarting the controlled ‘self-destruct’ mechanisms that act as a critical safeguard against cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ansieau, S., Scheffrahn, I., Mosialos, G., Brand, H. E., Duyster, J., Kaye, K. M., Harada, J. N., Dougall, B., Hübinger, G., Kieff, E. D., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14053 · Cited by 75
Self-citationRetractedHayden, M. S., & Ghosh, S. (2004) · Genes & Development · doi:10.1101/gad.1228704 · Cited by 3,842
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Immunofluorescence in Cells Derived from Burkitt's Lymphoma
Henle, G., & Henle, W. (1966) · Journal of Bacteriology · doi:10.1128/jb.91.3.1248-1256.1966 · Cited by 1,439
Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells
Yates, J. L., Warren, N., & Sugden, B. (1985) · Nature · doi:10.1038/313812a0 · Cited by 1,292
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Self-citationHenderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., & Rickinson, A. (1991) · Cell · doi:10.1016/0092-8674(91)90007-l · Cited by 1,168
Self-citationMosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995) · Nature · doi:10.1038/375685a0 · Cited by 823
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Self-citationEpstein–Barr Virus Replication in Oropharyngeal Epithelial Cells
Sixbey, J. W., Nedrud, J. G., Raab-Traub, N., Hanes, R. A., & Pagano, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405103101905 · Cited by 723
Yates, J., Warren, N., Reisman, D., & Sugden, B. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.12.3806 · Cited by 668
Kang, D.-C., Gopalkrishnan, R. V., Wu, Q., Jankowsky, E., Pyle, A. M., & Fisher, P. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022637199 · Cited by 651
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., & Raab-Traub, N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509143331103 · Cited by 620
Caldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
Henle, W., Diehl, V., Kohn, G., zur Hausen, H., & Henle, G. (1967) · Science · doi:10.1126/science.157.3792.1064 · Cited by 588
Lerner, M. R., Andrews, N. C., Miller, G., & Steitz, J. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.2.805 · Cited by 575
Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2309-2318.1990 · Cited by 566
Self-citationLevitskaya, J., Sharipo, A., Leonchiks, A., Ciechanover, A., & Masucci, M. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12616 · Cited by 562
Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed
Cai, X., Schäfer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N., & Cullen, B. R. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020023 · Cited by 559
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
Rawlins, D. R., Milman, G., Hayward, S. D., & Hayward, G. S. (1985) · Cell · doi:10.1016/0092-8674(85)90282-x · Cited by 506
Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., & Mosialos, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7098 · Cited by 491
Self-citationEpstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Cohen, J. I., Wang, F., Mannick, J., & Kieff, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9558 · Cited by 483
Self-citationPope, J. H., Horne, M. K., & Scott, W. M. (1968) · International Journal of Cancer · doi:10.1002/ijc.2910030619 · Cited by 472
Ishida, T., Mizushima, S.-I., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28745 · Cited by 472
Self-citationNachmani, D., Stern-Ginossar, N., Sarid, R., & Mandelboim, O. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.003 · Cited by 470
Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κ
Henkel, T., Ling, P. D., Hayward, S. D., & Peterson, M. G. (1994) · Science · doi:10.1126/science.8016657 · Cited by 455
Sugden, B., Marsh, K., & Yates, J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.2.410 · Cited by 440
Antibodies to Epstein-Barr Virus in Burkitt's Lymphoma and Control Groups 2
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.5.1147 · Cited by 415
Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1β Production
Haneklaus, M., Gerlic, M., Kurowska-Stolarska, M., Rainey, A.-A., Pich, D., McInnes, I. B., Hammerschmidt, W., O’Neill, L. A. J., & Masters, S. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200312 · Cited by 411
Laherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35741-7 · Cited by 409
Izumi, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12592 · Cited by 394
Self-citationTomkinson, B., Robertson, E., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2014-2025.1993 · Cited by 388
Self-citationWang, D., Liebowitz, D., Wang, F., Gregory, C. D., Rickinson, A. B., Larson, R. A., Springer, T. A., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4173-4184.1988 · Cited by 384
Self-citationCovalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line
Lindahl, T., Adams, A., Bjursell, G., Bornkamm, G. W., Kaschka-Dierich, C., & Jehn, U. (1976) · Journal of Molecular Biology · doi:10.1016/0022-2836(76)90331-4 · Cited by 373
Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation
Dawson, W. O., Rickinson, A. B., & Young, L. S. (1990) · Nature · doi:10.1038/344777a0 · Cited by 366
Reisman, D., & Sugden, B. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.3838 · Cited by 366
Valentine, R., Dawson, C. W., Hu, C., Shah, K. M., Owen, T. J., Date, K. L., Maia, S. P., Shao, J., Arrand, J. R., Young, L. S., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-1 · Cited by 353
CTCF and Cohesin: Linking Gene Regulatory Elements with Their Targets
Merkenschlager, M., & Odom, D. T. (2013) · Cell · doi:10.1016/j.cell.2013.02.029 · Cited by 345
Hino, R., Uozaki, H., Murakami, N., Ushiku, T., Shinozaki, A., Ishikawa, S., Morikawa, T., Nakaya, T., Sakatani, T., Takada, K., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3070 · Cited by 344
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors
Birkenbach, M., Josefsen, K., Yalamanchili, R., Lenoir, G., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2209-2220.1993 · Cited by 327
Self-citationMiller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B., & Kieff, E. (1995) · Immunity · doi:10.1016/s1074-7613(95)80040-9 · Cited by 320
Self-citationEBV MicroRNAs in Primary Lymphomas and Targeting of CXCL-11 by ebv-mir-BHRF1-3
Xia, T., O’Hara, A. J., Araújo, I., Barreto, J., Carvalho, E. G., Sapucaia, J. B., Ramos, J. C., Luz, E., Pedroso, C., Manrique, M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5126 · Cited by 319
Rosa, M. D., Gottlieb, E., Lerner, M. R., & Steitz, J. A. (1981) · Molecular and Cellular Biology · doi:10.1128/mcb.1.9.785 · Cited by 315
EB virus‐encoded RNAs are recognized by RIG‐I and activate signaling to induce type I IFN
Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T., & Takada, K. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601314 · Cited by 311
Iwakiri, D., Zhou, L., Samanta, M., Matsumoto, M., Ebihara, T., Seya, T., Imai, S., Fujieda, M., Kawa, K., & Takada, K. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081761 · Cited by 309
Early events in Epstein-Barr virus infection of human B lymphocytes
Alfieri, C., Birkenbach, M., & Kieff, E. (1991) · Virology · doi:10.1016/0042-6822(91)90893-g · Cited by 303
Self-citationSelf-Inhibition of Synthesis and Antigen Presentation by Epstein-Barr Virus-Encoded EBNA1
Yin, Y., Manoury, B., & Fåhraeus, R. (2003) · Science · doi:10.1126/science.1088902 · Cited by 296
Yates, J. L., & Guan, N. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.483-488.1991 · Cited by 292
Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus
Fåhræus, R., Rymo, L., Rhim, J. S., & Klein, G. (1990) · Nature · doi:10.1038/345447a0 · Cited by 286
Scholle, F., Bendt, K. M., & Raab-Traub, N. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10681-10689.2000 · Cited by 277
Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma
Nanbo, A., Inoue, K., Adachi‐Takasawa, K., & Takada, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.954 · Cited by 276
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.
Baichwal, V. R., & Sugden, B. (1988) · PubMed · Cited by 275
Lupton, S., & Levine, A. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.10.2533 · Cited by 274
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
Komano, J. A., Maruo, S., Kurozumi, K., Oda, T., & Takada, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9827-9831.1999 · Cited by 268
NF-κB inhibition causes spontaneous apoptosis in Epstein–Barr virus-transformed lymphoblastoid cells
Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J., & Kieff, E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100119497 · Cited by 259
Self-citation(1985) · The Lancet · doi:10.1016/s0140-6736(85)90708-1 · Cited by 258
Sugden, B., & Warren, N. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2644-2649.1989 · Cited by 257
Miller, C. L., Lee, J. H., Kieff, E., & Longnecker, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.772 · Cited by 257
Self-citationFries, K. L., Miller, W. E., & Raab-Traub, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8653-8659.1996 · Cited by 255
Mancao, C., & Hammerschmidt, W. (2007) · Blood · doi:10.1182/blood-2007-05-090142 · Cited by 250
Miller, W. E., Earp, H. S., & Raab-Traub, N. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4390-4398.1995 · Cited by 237
Mannick, J. B., Cohen, J. I., Birkenbach, M., Marchini, A., & Kieff, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6826-6837.1991 · Cited by 236
Self-citationNikitin, P. A., Yan, C. M., Forte, E., Bocedi, A., Tourigny, J. P., White, R. E., Allday, M. J., Patel, A., Dave, S. S., Kim, W., et al. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.004 · Cited by 235
Cahir-McFarland, E. D., Carter, K., Rosenwald, A., Giltnane, J. M., Henrickson, S. E., Staudt, L. M., & Kieff, E. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.4108-4119.2004 · Cited by 233
Self-citationHolowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J., & Frappier, L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303977200 · Cited by 228
Devergne, O., McFarland, E. C., Mosialos, G., Izumi, K. M., Ware, C. F., & Kieff, E. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7900-7908.1998 · Cited by 228
Self-citationKaye, K. M., Devergne, O., Harada, J. N., Izumi, K. M., Yalamanchili, R., Kieff, E., & Mosialos, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11085 · Cited by 226
Self-citationYoung, L. S., Lau, R., Rowe, M., Niedobitek, G., Packham, G., Shanahan, F., Rowe, D. T., Greenspan, D., Greenspan, J. S., & Rickinson, A. B. (1991) · Journal of Virology · doi:10.1128/jvi.65.6.2868-2874.1991 · Cited by 226
Seto, E., Moosmann, A., Grömminger, S., Walz, N., Grundhoff, A., & Hammerschmidt, W. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001063 · Cited by 220
Izumi, K. M., Kaye, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1447 · Cited by 218
Self-citationBochkarev, A., Barwell, J. A., Pfuetzner, R. A., Bochkareva, E., Frappier, L., & Edwards, A. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81056-9 · Cited by 214
Wysokenski, D. A., & Yates, J. L. (1989) · Journal of Virology · doi:10.1128/jvi.63.6.2657-2666.1989 · Cited by 211
Zhao, B., Zou, J., Wang, H., Johannsen, E., Peng, C.-W., Quackenbush, J., Mar, J. C., Morton, C. C., Freedman, M. L., Blacklow, S. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108892108 · Cited by 209
Self-citationRescue of “crippled” germinal center B cells from apoptosis by Epstein-Barr virus
Mancao, C., Altmann, M., Jungnickel, B., & Hammerschmidt, W. (2005) · Blood · doi:10.1182/blood-2005-06-2341 · Cited by 203
Katze, M. G., Wambach, M., Wong, M. L., Garfinkel, M., Meurs, E., Chong, K., Williams, B. R., Hovanessian, A. G., & Barber, G. N. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5497 · Cited by 203
Kitagawa, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6742 · Cited by 202
Functional domains of Epstein-Barr virus nuclear antigen EBNA-1
Ambinder, R. F., Mullen, M. A., Chang, Y. N., Hayward, G. S., & Hayward, S. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.3.1466-1478.1991 · Cited by 201
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
Baumforth, K. R. N., Birgersdotter, A., Reynolds, G. M., Wei, W., Kapatai, G., Flavell, J. R., Kalk, E., Piper, K., Lee, S., Machado, L., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070845 · Cited by 200
Replication of latent Epstein-Barr virus genomes in Raji cells
Adams, A. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1743-1746.1987 · Cited by 198
Eliopoulos, A. G., Dawson, C., Mosialos, G., Floettmann, J. E., Rowe, M., Armitage, R. J., Dawson, J., Zapata, J. M., Kerr, D., Wakelam, M. J. O., et al. (1996) · PubMed · Cited by 197
Self-citationHarada, S., & Kieff, E. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6611-6618.1997 · Cited by 192
Self-citationGahn, T. A., & Sugden, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2633-2636.1995 · Cited by 191
Reisman, D., Yates, J., & Sugden, B. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1822-1832.1985 · Cited by 186
Anderton, E., Yee, J., Smith, P., Crook, T., White, R. E., & Allday, M. J. (2008) · Oncogene · doi:10.1038/sj.onc.1210668 · Cited by 185
Epstein-Barr Virus Latent Membrane Protein 2A Activates β-Catenin Signaling in Epithelial Cells
Morrison, J. A., Klingelhutz, A. J., & Raab-Traub, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12276-12284.2003 · Cited by 185
Cohen, J. I., Wang, F., & Kieff, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2545-2554.1991 · Cited by 183
Self-citationLongnecker, R., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2319-2326.1990 · Cited by 178
Self-citationPaschos, K., Smith, P., Anderton, E., Middeldorp, J. M., White, R. E., & Allday, M. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000492 · Cited by 177
VanArsdale, T. L., VanArsdale, S. L., Force, W. R., Walter, B. N., Mosialos, G., Kieff, E., Reed, J. C., & Ware, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2460 · Cited by 175
Self-citationKaye, K. M., Izumi, K. M., Mosialos, G., & Kieff, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.675-683.1995 · Cited by 173
Self-citationSharp, T. V., Schwemmle, M., Jeffrey, I., Laing, K., Mellor, H., Proud, C. G., Hilse, K., & Clemens, M. J. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.19.4483 · Cited by 173
Moorthy, R. K., & Thorley-Lawson, D. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1638-1646.1993 · Cited by 172
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
Hung, S. C., Kang, M.-S., & Kieff, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1865 · Cited by 169
Self-citationMiller, W. E., Mosialos, G., Kieff, E., & Raab-Traub, N. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.586-594.1997 · Cited by 167
Self-citationShire, K., Ceccarelli, D. F. J., Avolio-Hunter, T. M., & Frappier, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2587-2595.1999 · Cited by 167
Robertson, E. S., Grossman, S., Johannsen, E., Miller, C., Lin, J., Tomkinson, B., & Kieff, E. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.3108-3116.1995 · Cited by 166
Self-citationEBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C., Gribben, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58092 · Cited by 166
Knight, J. S., Sharma, N., & Robertson, E. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503886102 · Cited by 164
Sivachandran, N., Sarkari, F., & Frappier, L. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000170 · Cited by 162
Latent Membrane Protein 2A-Mediated Effects on the Phosphatidylinositol 3-Kinase/Akt Pathway
Swart, R. E., Ruf, I. K., Sample, J. T., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.22.10838-10845.2000 · Cited by 155
P32/TAP, a Cellular Protein That Interacts with EBNA-1 of Epstein–Barr Virus
Wang, Y., Finan, J. E., Middeldorp, J. M., & Hayward, S. D. (1997) · Virology · doi:10.1006/viro.1997.8739 · Cited by 154
Longnecker, R., Druker, B. J., Roberts, T. M., & Kieff, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3681-3692.1991 · Cited by 148
Self-citationMiddleton, T. L., & Sugden, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.4067-4071.1994 · Cited by 146
The Minimal Replicator of Epstein-Barr Virus oriP
Yates, J. L., Camiolo, S. M., & Bashaw, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4512-4522.2000 · Cited by 146
Izumi, K. M., McFarland, E. C., Ting, A. T., Riley, E. A., Seed, B., & Kieff, E. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5759 · Cited by 146
Self-citationMaruo, S., Zhao, B., Johannsen, E., Kieff, E. D., Zou, J., & Takada, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019599108 · Cited by 145
Self-citationSkalska, L., White, R. E., Franz, M., Ruhmann, M., & Allday, M. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000951 · Cited by 145
Wood, V. H. J., O’Neil, J. D., Wei, W., Stewart, S. E., Dawson, W. O., & Young, L. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210496 · Cited by 144
Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression
Carter, K. L., Cahir-McFarland, E. D., & Kieff, E. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10427-10436.2002 · Cited by 144
Self-citationThe microRNAs of Epstein–Barr Virus are expressed at dramatically differing levels among cell lines
Pratt, Z. L., Kuzembayeva, M., Sengupta, S., & Sugden, B. (2009) · Virology · doi:10.1016/j.virol.2009.01.006 · Cited by 143
Higuchi, M., Izumi, K. M., & Kieff, E. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081075298 · Cited by 138
Self-citationEpstein–Barr virus latent membrane protein 1 activation of NF-κB through IRAK1 and TRAF6
Luftig, M. A., Prinarakis, E., Yasui, T., Tsichritzis, T., Cahir-McFarland, E. D., Inoue, J., Nakano, H., Mak, T. W., Yeh, W., Li, X., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136756100 · Cited by 138
Self-citationSylla, B. S., Hung, S. C., Davidson, D. M., Hatzivassiliou, E., Malinin, N. L., Wallach, D., Gilmore, T. D., Kieff, E., & Mosialos, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10106 · Cited by 137
Self-citationSharipo, A., Imreh, M. P., Leonchiks, A., Imreh, S., & Masucci, M. G. (1998) · Nature Medicine · doi:10.1038/nm0898-939 · Cited by 136
Establishment of Cell Lines from Peripheral Leucocytes in Infectious Mononucleosis
Pope, J. H. (1967) · Nature · doi:10.1038/216810a0 · Cited by 132
Knight, J. S., Lan, K., Subramanian, C., & Robertson, E. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4261-4272.2003 · Cited by 129
Marchini, A., Tomkinson, B. E., Cohen, J. I., & Kieff, E. D. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.5991-6000.1991 · Cited by 128
Self-citationEpstein-Barr Virus LMP2A-Induced B-Cell Survival in Two Unique Classes of EμLMP2A Transgenic Mice
Caldwell, R. G., Brown, R. C., & Longnecker, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1101-1113.2000 · Cited by 128
O’Neil, J. D., Owen, T. J., Wood, V. H. J., Date, K. L., Valentine, R., Chukwuma, M. B., Arrand, J. R., Dawson, W. O., & Young, L. S. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/003392-0 · Cited by 127
Functions of the Epstein-Barr Virus EBNA1 Protein in Viral Reactivation and Lytic Infection
Sivachandran, N., Wang, X., & Frappier, L. (2012) · Journal of Virology · doi:10.1128/jvi.00013-12 · Cited by 126
Wu, H., Kapoor, P., & Frappier, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2480-2490.2002 · Cited by 125
Yajima, M., Kanda, T., & Takada, K. (2005) · Journal of Virology · doi:10.1128/jvi.79.7.4298-4307.2005 · Cited by 123
Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., & Thorley‐Lawson, D. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509311102 · Cited by 121
Saha, A., Murakami, M., Kumar, P., Bajaj, B. G., Sims, K., & Robertson, E. S. (2009) · Journal of Virology · doi:10.1128/jvi.02408-08 · Cited by 120
Longnecker, R., Miller, C. L., Miao, X. Q., Tomkinson, B. E., & Kieff, E. D. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2006-2013.1993 · Cited by 119
Self-citationBIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
Paschos, K., Parker, G. A., Watanatanasup, E., White, R. E., & Allday, M. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks391 · Cited by 119
Sarkari, F., Sanchez-Alcaraz, T., Wang, S., Holowaty, M. N., Sheng, Y., & Frappier, L. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000624 · Cited by 119
Yi, F., Saha, A., Murakami, M., Kumar, P., Knight, J. S., Cai, Q., Choudhuri, T., & Robertson, E. S. (2009) · Virology · doi:10.1016/j.virol.2009.03.027 · Cited by 118
Flavell, J. R., Baumforth, K. R. N., Wood, V. H. J., et al. (2007) · Blood · doi:10.1182/blood-2006-11-059881 · Cited by 118
Iwakiri, D., Sheen, T., Chen, J.-Y., Huang, D. P., & Takada, K. (2004) · Oncogene · doi:10.1038/sj.onc.1208357 · Cited by 118
Ruf, I. K., Rhyne, P., Yang, C., Cleveland, J. L., & Sample, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10223-10228.2000 · Cited by 118
Aiyar, A. A., Tyree, C. M., & Sugden, B. (1998) · The EMBO Journal · doi:10.1093/emboj/17.21.6394 · Cited by 117
Middleton, T. L., & Sugden, B. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.489-495.1992 · Cited by 115
Zhao, B., Marshall, D. R., & Sample, C. E. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4228-4236.1996 · Cited by 115
Wang, D., Liebowitz, D., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.7.2337-2346.1988 · Cited by 114
Self-citationTong, X., Wang, F., Thut, C. J., & Kieff, E. D. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.585-588.1995 · Cited by 114
Self-citationFukuda, M., & Longnecker, R. (2007) · Journal of Virology · doi:10.1128/jvi.00537-07 · Cited by 112
Jones, C. H., Hayward, S. D., & Rawlins, D. R. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.101-110.1989 · Cited by 107
Zhao, B., & Sample, C. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5151-5160.2000 · Cited by 107
Morrison, J. A., & Raab‐Traub, N. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2375-2382.2005 · Cited by 105
Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D., & Takada, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604919104 · Cited by 104
EBNA1 regulates cellular gene expression by binding cellular promoters
Canaan, A., Haviv, I., Urban, A. E., Schulz, V., Hartman, S., Zhang, Z., Palejev, D., Deisseroth, A., Lacy, J., Snyder, M. P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911676106 · Cited by 103
Epstein-Barr Virus Nuclear Antigen 1 Hijacks the Host Kinase CK2 To Disrupt PML Nuclear Bodies
Sivachandran, N., Cao, J. Y., & Frappier, L. (2010) · Journal of Virology · doi:10.1128/jvi.01183-10 · Cited by 103
Ma, P., & Lundgren, E. (1992) · PubMed · Cited by 100
Plasmid maintenance of derivatives of oriP of Epstein-Barr virus
Kirchmaier, A. L., & Sugden, B. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.1280-1283.1995 · Cited by 99
Sutkowski, N., Chen, G., Calderon, G., & Huber, B. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7852-7860.2004 · Cited by 98
Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells
Rymo, L. (1979) · Journal of Virology · doi:10.1128/jvi.32.1.8-18.1979 · Cited by 98
Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus
Kirchmaier, A. L., & Sugden, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1766-1775.1997 · Cited by 98
Allday, M. J., & Farrell, P. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.6.3491-3498.1994 · Cited by 95
McClellan, M. J., Wood, C. D., Ojeniyi, O. O., Cooper, T. J., Kanhere, A., Arvey, A. J., Webb, H., Palermo, R. D., Harth-Hertle, M. L., Kempkes, B., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003636 · Cited by 95
Dutton, A., Woodman, C. B. J., Chukwuma, M. B., Last, J. I. K., Wei, W., Vockerodt, M., Baumforth, K. R. N., Flavell, J. R., Rowe, M., Taylor, A. M. R., et al. (2006) · Blood · doi:10.1182/blood-2006-05-020545 · Cited by 94
Yin, Q., & Flemington, E. K. (2005) · Virology · doi:10.1016/j.virol.2005.11.021 · Cited by 88
Gan, Y. J., Chodosh, J., Morgan, A. J., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.519-526.1997 · Cited by 88
Dantuma, N. P., Heessen, S., Lindsten, K., Jellne, M., & Masucci, M. G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140217397 · Cited by 87
Skalska, L., White, R. E., Parker, G. A., Sinclair, A. J., Paschos, K., & Allday, M. J. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003187 · Cited by 87
Jiang, S., Willox, B., Zhou, H., Holthaus, A. M., Wang, A., Shi, T. T., Maruo, S., Kharchenko, P. V., Johannsen, E., Kieff, E. D., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321704111 · Cited by 87
Self-citationHampar, B., Tanaka, A., Nonoyama, M., & Derge, J. G. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.3.631 · Cited by 87
Saha, A., Halder, S., Upadhyay, S. K., Lu, J. L., Kumar, P., Murakami, M., Cai, Q., & Robertson, E. S. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001275 · Cited by 85
AUF1/hnRNP D is a novel protein partner of the EBER1 noncoding RNA of Epstein-Barr virus
Lee, N., Pimienta, G., & STEITZ, J. A. (2012) · RNA · doi:10.1261/rna.034900.112 · Cited by 84
Shire, K., Kapoor, P., Jiang, K., Hing, M. N. T., Sivachandran, N., Nguyen, T., & Frappier, L. (2006) · Journal of Virology · doi:10.1128/jvi.02682-05 · Cited by 82
Kaye, K. M., Izumi, K. M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., & Kieff, E. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10525-10530.1999 · Cited by 82
Self-citationIkeda, M., & Longnecker, R. (2006) · Virology · doi:10.1016/j.virol.2006.10.046 · Cited by 81
Banerjee, S., Lu, J. L., Cai, Q., Saha, A., Jha, H. C., Dzeng, R. K., & Robertson, E. S. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003314 · Cited by 81
Epstein-Barr Virus Nuclear Antigen 1 Forms a Complex with the Nuclear Transporter Karyopherin α2
Fischer, N., Kremmer, E., Lautscham, G., Mueller‐Lantzsch, N., & Grässer, F. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.3999 · Cited by 80
Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22
Fok, V., Mitton-Fry, R. M., Grech, A., & STEITZ, J. A. (2006) · RNA · doi:10.1261/rna.2339606 · Cited by 80
Frappier, L., Goldsmith, K., & Bendell, L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42220-4 · Cited by 79
Epstein-Barr Virus EBNA1 Protein Regulates Viral Latency through Effects on let-7 MicroRNA and Dicer
Mansouri, S., Pan, Q., Blencowe, B. J., Claycomb, J. M., & Frappier, L. (2014) · Journal of Virology · doi:10.1128/jvi.01785-14 · Cited by 77
Allen, M. D., Young, L. S., & Dawson, W. O. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1789-1802.2005 · Cited by 77
Functional Analyses of the EBNA1 Origin DNA Binding Protein of Epstein-Barr Virus
Ceccarelli, D. F. J., & Frappier, L. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.4939-4948.2000 · Cited by 77
Discovery of Selective Inhibitors Against EBNA1 via High Throughput In Silico Virtual Screening
Li, N., Thompson, S. B., Schultz, D., Zhu, W., Jiang, H., Luo, C., & Lieberman, P. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010126 · Cited by 75
Portal, D., Zhou, H., Zhao, B., Kharchenko, P. V., Lowry, E. L., Wong, L., Quackenbush, J. F., Holloway, D. T., Jiang, S., Lu, Y. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317608110 · Cited by 75
Self-citationLo, A. K., Lo, K. W., Ko, C., Young, L. S., & Dawson, W. O. (2013) · The Journal of Pathology · doi:10.1002/path.4201 · Cited by 74
Martin, J. M., Novack, D. V., Korsmeyer, S. J., & Sugden, B. (1993) · Journal of Virology · doi:10.1128/jvi.67.9.5269-5278.1993 · Cited by 72
Izumi, K. M., Kaye, K. M., & Kieff, E. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4369-4376.1994 · Cited by 71
Self-citationMiller, C. L., Lee, J. H., Kieff, E. D., Burkhardt, A. L., Bolen, J. B., & Longnecker, R. (1994) · PubMed · Cited by 71
Self-citationGoldsmith, K., Bendell, L., & Frappier, L. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3418-3426.1993 · Cited by 70
Chang, M. S., Kim, D. H., Roh, J., Middeldorp, J. M., Kim, Y. S., Kim, S., Han, S., Kim, C. W., Lee, B. L., Kim, W. H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.00955-13 · Cited by 70
Harth-Hertle, M. L., Scholz, B. A., Erhard, F., Glaser, L. V., Dölken, L., Zimmer, R., & Kempkes, B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003638 · Cited by 68
Bochkarev, A. V., Bochkareva, E. S., Frappier, L., & Edwards, A. M. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2247 · Cited by 67
Epstein-Barr Virus-Encoded RNAs: Key Molecules in Viral Pathogenesis
Iwakiri, D. (2014) · Cancers · doi:10.3390/cancers6031615 · Cited by 66
Saha, A., Bamidele, A. O., Murakami, M., & Robertson, E. S. (2010) · Journal of Virology · doi:10.1128/jvi.02279-10 · Cited by 65
Scholle, F., Longnecker, R., & Raab‐Traub, N. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4767-4775.1999 · Cited by 63
Thornburg, N. J., & Raab‐Traub, N. (2007) · Journal of Virology · doi:10.1128/jvi.01601-07 · Cited by 60
Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module
Engels, N., Merchant, M., Pappu, R., Chan, A. C., Longnecker, R., & Wienands, J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.3.255 · Cited by 60
Sarkari, F., Wang, X., Nguyen, T., & Frappier, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016598 · Cited by 59
Saha, A., Lu, J. L., Morizur, L., Upadhyay, S. K., Mahadesh Prasad, A. J., & Robertson, E. S. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002573 · Cited by 59
EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity
Wang, H., Nicholas, M. W., Conway, K. L., Sen, P., Diz, R., Tisch, R., & Clarke, S. H. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.2793 · Cited by 59
Kitamura, R., Sekimoto, T., Ito, S., Harada, S., Yamagata, H., Masai, H., Yoneda, Y., & Yanagi, K. (2006) · Journal of Virology · doi:10.1128/jvi.80.4.1979-1991.2006 · Cited by 59
Lin, Z., Wan, X. H., Jiang, R., Deng, L., Gao, Y., Tang, J., Yu, Y., Zhao, W., Yan, X., Yao, K., et al. (2014) · Journal of Virology · doi:10.1128/jvi.01867-14 · Cited by 58
Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda
Geser, A., Lenoir, G., Anvret, M., Bornkamm, G. W., Klein, G., Williams, E. H., Wright, D. H., & de Thé, G. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(93)90009-t · Cited by 57
Katze, M. G., Wambach, M., Wong, M., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.11.5497-5505.1991 · Cited by 57
Fish, K., Chen, J., & Longnecker, R. (2013) · Blood · doi:10.1182/blood-2013-07-517649 · Cited by 56
Liu, H., Chen, C.-C., Wu, C., Huang, Y., Liu, S., Liang, Y. J., Chang, K.-P., & Chang, Y. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002690 · Cited by 56
Anderson, L. J., & Longnecker, R. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/001461-0 · Cited by 56
Epstein-Barr virus induces invasion and metastasis factors.
Wakisaka, N., & Pagano, J. S. (2003) · PubMed · Cited by 53
Cited by
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
Epstein-Barr virus and multiple sclerosis
Robinson, W. H., & Steinman, L. (2022) · Science · doi:10.1126/science.abm7930 · Cited by 310
Serquiña, A. K. P., Tagawa, T., Oh, D., Mahesh, G., & Ziegelbauer, J. M. (2021) · mBio · doi:10.1128/mbio.02907-21 · Cited by 24
Metadata
- Authors
- Kang, M.-S., & Kieff, E.
- Venue
- Experimental & Molecular Medicine
- Published
- 2015-01-23
- Volume
- 47
- Issue
- 1
- Pages
- e131-e131
- ISSN
- 1226-3613 (ISSN-L)
- 2092-6413
- OpenAlex
- W2154255170
- Cited by
- 361
- References
- 235
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.